Skip to content

Control Formula

OTHER15 trials

Sponsors

Azienda Ospedaliero Universitaria Maggiore della Carita, HiPP GmbH & Co. Vertrieb KG, Abbott Nutrition, Société des Produits Nestlé (SPN), Danone Nutricia

Conditions

Atopic Dermatitis (AD)Atopic DiseasesCognitive ChangeCognitive DevelopmentColdCow Milk Protein AllergyCow's Milk Protein AllergyDisturbance of Growth

Unknown Phase

Nutritional Support in Pressure Ulcer Patients
CompletedNCT01107197
Azienda Ospedaliero Universitaria Maggiore della CaritaPressure Ulcers
Start: 2010-02-28End: 2012-11-30Updated: 2014-02-12
Low-protein Infant Formula With Partial or Extensive Proteinhydrolysate 4 Year Follow-up
CompletedNCT01143233
HiPP GmbH & Co. Vertrieb KGDisturbance of Growth
Start: 2010-04-30End: 2017-08-31Updated: 2017-11-30
Evaluation of Safety and Efficacy of New Infant Formula in Infantile Colic
TerminatedNCT01721850
HiPP GmbH & Co. Vertrieb KGInfantile Colic
Start: 2011-12-31End: 2019-04-30Updated: 2022-01-20
Growth and Tolerance of Infants Fed Infant Formulas
CompletedNCT01808105
Abbott NutritionGrowth and Tolerance
Start: 2013-04-30End: 2014-02-28Updated: 2014-06-02
The Combiotic-Study
TerminatedNCT02221687
HiPP GmbH & Co. Vertrieb KGHealthy Term Infants
Start: 2014-08-31End: 2021-04-30Updated: 2022-01-20
Prevention of Allergic Diseases in Infants
CompletedNCT03489733
HiPP GmbH & Co. Vertrieb KGAtopic Diseases
Start: 2018-07-09End: 2025-10-30Updated: 2026-03-09
Efficacy of a Nutrient Blend in Improving Neurocognitive and Behavioral Outcomes in Infants: a Randomized, Controlled, Intervention Study
CompletedNCT05310396
Société des Produits Nestlé (SPN)Cognitive Development, Infant Nutrition
Start: 2022-10-07End: 2025-09-29Updated: 2025-12-04
Effect of Partially Hydrolyzed, Whey-based Infant Formulas on Growth and Tolerability in Healthy Term Infants
RecruitingNCT05868408
Société des Produits Nestlé (SPN)Growth and Development, Infant Development, Infant Formula +2
Start: 2023-08-17End: 2028-06-30Target: 234Updated: 2025-12-19
An Exploratory Trial in Hong Kong to Explore the Effect of a New Formula
CompletedNCT06122272
Danone NutriciaHealthy Subjects
Start: 2023-12-19End: 2025-05-30Updated: 2025-08-05
Improved Cognitive Outcomes Associated With Feihe HMO With DHA/ARA in Infant Formula
CompletedNCT06146387
Heilongjiang Feihe Dairy Co. Ltd.Cognitive Change
Start: 2023-11-14End: 2025-04-03Updated: 2025-12-08
Improved Immunology Outcomes Associated With Lactoferrin Fortified With HMO in Infant Formula
CompletedNCT06158659
Heilongjiang Feihe Dairy Co. Ltd.Cold, Flu
Start: 2023-11-14End: 2025-04-03Updated: 2025-12-08
Improved Gut Health Outcomes Associated With Probiotics Fortified With Hydrolyzed Whey Protein in Infant Formula
CompletedNCT06159088
Heilongjiang Feihe Dairy Co. Ltd.Gastrointestinal Diseases, Gut Health
Start: 2023-11-14End: 2025-04-03Updated: 2025-12-08
Effect of a Hydrolyzed Rice Protein-based Formula on Growth, Tolerance, and Health-related Quality of Life in Infants With Cow's Milk Protein Allergy.
RecruitingNCT06633250
Société des Produits Nestlé (SPN)Cow Milk Protein Allergy
Start: 2024-10-25End: 2026-08-31Target: 104Updated: 2025-12-26
Hypoallergenicity of a Hydrolyzed Rice Protein-based Formula in Infants and Young Children With Cow's Milk Protein Allergy
RecruitingNCT06633289
Société des Produits Nestlé (SPN)Cow's Milk Protein Allergy
Start: 2024-11-05End: 2026-10-31Target: 67Updated: 2025-07-01
Effect of Partially Hydrolyzed Formula With Synbiotics on Skin Barrier Function
RecruitingNCT06943469
Société des Produits Nestlé (SPN)Atopic Dermatitis (AD)
Start: 2025-04-10End: 2028-11-30Target: 400Updated: 2025-12-12

Related Papers